Kampala, Uganda — May 6, 2026 — The Ministry of Health Uganda has officially rolled out a new long-acting HIV prevention injection known as lenacapavir, now available at selected health facilities across the country.
The breakthrough drug, which has shown nearly 100% effectiveness in clinical trials, is expected to significantly reduce new HIV infections, especially among high-risk groups.
This breakthrough could transform how millions protect themselves from HIV in Uganda.
— Ministry of Health- Uganda (@MinofHealthUG) May 2, 2026
What is Lenacapavir and How Does It Work?
Lenacapavir is a long-acting injectable drug used for HIV prevention. Unlike daily oral PrEP pills, this injection is administered once every six months, making it easier for individuals to stay protected.
According to health officials, a single dose provides protection for up to six months, offering a more convenient and discreet option for HIV prevention.
Where to Get the Lenacapavir Injection in Uganda
The Ministry has confirmed that the drug is available for free at the following health facilities:
Kampala
AIDS Information Centre Kampala Special Clinic
China-Uganda Friendship Hospital, Naguru
Kiruddu National Referral Hospital
Mulago National Referral Hospital (MARPI STI Clinic)
Health officials during the rollout of Lenacapavir, a long-acting HIV prevention injection in Uganda
Other Regions
Gulu Regional Referral Hospital
Kitgum Hospital
Mbarara Regional Referral Hospital
Mbale Regional Referral Hospital
Kabale Regional Referral Hospital
Jinja Regional Referral Hospital
Mubende Regional Referral Hospital
Masaka Regional Referral Hospital
Entebbe Regional Referral Hospital
Soroti Regional Referral Hospital
Fort Portal Regional Referral Hospital
Arua Regional Referral Hospital
Yumbe Regional Referral Hospital
The drug was officially launched on April 17, 2026, at Lira Regional Referral Hospital by Health Minister Jane Ruth Aceng.
Dr. Jane Ruth Acheng, Minister of Health
During the launch, officials warned that Uganda risks reversing gains made in the fight against HIV if prevention efforts are not strengthened.
According to the Uganda AIDS Commission, thousands of new HIV infections are still recorded every year, particularly among:
Young women
Sex workers
Fishing communities
Other high-risk groups
The introduction of lenacapavir adds to existing prevention options such as
It is recommended for individuals at high risk of HIV infection. Visit a nearby facility for assessment.
With its long-lasting protection and high effectiveness, Lenacapavir could be a game-changer in Uganda’s HIV prevention efforts. Ugandans are encouraged to visit the listed health facilities and consult medical professionals for guidance.
written by @enock katamba
enock katamba
Enock Katamba is a Ugandan Journalist and Founder of Uncovered UG, an independent digital news platform covering Uganda and international developments. He reports on politics, national affairs, entertainment, sports, business, education and other stories of public interest.